ExodusPoint Capital Management’s Core Laboratories CLB Stock Holding History

ExodusPoint Capital Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-98,003	Closed	-$1.13M	–	1589
2025 Q2	$1.13M	Buy	98,003 +21,082	+27%	+$250K	0.01%	922
2025 Q1	$1.15M	Buy	+76,921	New	+$1.29M	0.01%	878
2024 Q4	–	Sell	-41,762	Closed	-$774K	–	1593
2024 Q3	$774K	Buy	+41,762	New	+$839K	﹤0.01%	1049
2024 Q1	–	Sell	-18,643	Closed	-$329K	–	1542
2023 Q4	$329K	Buy	+18,643	New	+$376K	﹤0.01%	1153
2023 Q3	–	Sell	-12,343	Closed	-$287K	–	1751
2023 Q2	$287K	Sell	12,343 -58,456	-83%	-$1.32M	﹤0.01%	1557
2023 Q1	$1.56M	Buy	+70,799	New	+$1.66M	0.01%	985
2021 Q4	–	Sell	-63,362	Closed	-$1.76M	–	2205
2021 Q3	$1.76M	Buy	+63,362	New	+$1.93M	0.02%	779
2021 Q2	–	Sell	-25,419	Closed	-$732K	–	2398
2021 Q1	$732K	Buy	+25,419	New	+$868K	0.01%	1111
2020 Q3	–	Sell	-339,286	Closed	-$6.89M	–	1798
2020 Q2	$6.89M	Buy	+339,286	New	+$6.08M	0.18%	105

Other funds holding CLB

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

ExodusPoint Capital Management's CLB Position: Q3 2025 in Review

ExodusPoint Capital Management sold out of Core Laboratories (CLB) in Q3 2025, closing a stake of 98,003 shares — an estimated $1.13M sold.

ExodusPoint Capital Management first reported a position in CLB in Q2 2020 and held it in 9 quarters. The position peaked at $6.89M in Q2 2020. 190 funds tracked by Wall St. Rank hold CLB as of Q3 2025.

ExodusPoint Capital Management reported no remaining Core Laboratories position as of Q3 2025 after selling out during the quarter.
ExodusPoint Capital Management sold 98,003 Core Laboratories shares in Q3 2025, an estimated $1.13M.
ExodusPoint Capital Management first reported a position in Core Laboratories in Q2 2020 and held it in 9 quarters.
ExodusPoint Capital Management's Core Laboratories position peaked at $6.89M in Q2 2020.
190 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2025.

Based on ExodusPoint Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.